SERPINB1 and prostate carcinoma: In addition to Rab7, it was revealed that overexpression of serine protease inhibitor B1 (SERPINB1; also known as ILEU) promotes the motility of oral squamous cell carcinoma [36], but the epigenetic suppression of SERPINB1 predicts a poorer prognosis in prostate cancer patients [37].